文献速递母胎医学

更多产前筛查与更少诊断性操作的真正「代价」是什么?基因组时代的成本与权衡

What is the real "price" of more prenatal screening and fewer diagnostic procedures? Costs and trade-offs in the genomic era.
PubMed 文献 · Prenat Diagn · 2018-02-21

本文讨论游离DNA等筛查方法与染色体微阵列诊断检测之间的权衡。作者认为筛查不应被视为对知情选择的威胁,筛查性能提升使更多孕妇愿意依赖筛查,胎儿染色体异常检出率并未下降反而处于历史高位。全面告知各选项风险与获益可使结局更贴合孕妇偏好,同时减少诊断性检测并降低成本,确保孕妇获得充分信息是当代产前检测的主要挑战之一。

要点

  • 任何筛查方法(含游离DNA)的检出率均低于染色体微阵列100%诊断检测。
  • 筛查方法性能提升使更多孕妇愿意依赖筛查,胎儿染色体异常检出率并未下降,反而处于历史高位。
  • 全面告知各选项风险与获益可使结局更贴合孕妇偏好,同时减少诊断性检测并降低成本。

核心结论

  • 任何筛查方法(包括游离DNA)的检出率均低于染色体微阵列100%诊断检测。
  • 游离DNA筛查不应被视为对知情选择或最大化诊断检测获益的威胁。
  • 筛查方法性能大幅提升使更多孕妇愿意依赖筛查而无需诊断检测的确定性,胎儿染色体异常检出率并未下降,反而处于历史高位。
  • 全面提供所有选项并仔细全面解释各选项风险与获益,可使结局最贴合孕妇偏好,同时减少诊断性检测并降低成本。

研究设计与样本

  • 本文为产前筛查与诊断策略的成本与权衡论述,未报告系统检索范围或样本量。

主要发现

  • 任何筛查方法(包括游离DNA)的检出率均低于染色体微阵列100%诊断检测。
  • 筛查方法性能提升使更多孕妇愿意依赖筛查,胎儿染色体异常检出率并未下降,反而处于历史高位。
  • 普遍提供诊断检测并放弃对无并发症妊娠正常婴儿的预设,会带来经济与伦理后果。
  • 对部分孕妇而言,全面信息与诊断准确性很重要;向这些孕妇提供所有选项并仔细全面解释各选项风险与获益,可使结局最贴合其偏好,同时减少诊断性检测并降低成本。

关键数值与推荐

  • 任何筛查方法(包括游离DNA)的检出率均低于染色体微阵列100%诊断检测。
  • 向孕妇提供所有选项并仔细全面解释各选项风险与获益,可使结局最贴合孕妇偏好,同时减少诊断性检测并降低成本。

临床怎么用

  • 确保孕妇获得充分信息以做出知情决定是当代产前检测的主要挑战之一。
  • 向孕妇提供所有选项并仔细全面解释各选项风险与获益,可使结局最贴合孕妇偏好,同时减少诊断性检测并降低成本。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Any screening approach, including with cell-free DNA, will have an inferior detection rate compared with 100% diagnostic testing with chromosomal microarrays. Cell-free DNA-based screening, however, should not be seen as a threat to informed choice or maximising the benefits of diagnostic testing. Screening methods have become so much better that more women are now comfortable relying on such screening and do not need the certainty of a diagnostic test. This has not lead to a decline in detection of fetal chromosome abnormalities-in fact, we are now seeing historically high yields from prenatal screening. There are both economic and ethical consequences of offering universal diagnostic testing and abandoning the presumption of a normal infant in otherwise uncomplicated pregnancies. However, for some women, comprehensive information and diagnostic accuracy are important. Offering these women all options, with a careful and comprehensive explanation of the risks and benefits of each, results in outcomes that are best aligned with woman's preferences while at the same time requiring fewer diagnostic tests and lowering costs. It is one of the primary challenges of the modern era of prenatal testing to ensure that women receive sufficient information on which to make informed decisions.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Hui L, Norton M. What is the real "price" of more prenatal screening and fewer diagnostic procedures? Costs and trade-offs in the genomic era. Prenat Diagn. 2018. PMID: 29441593. doi:10.1002/pd.5228

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。